Enovis Corporation (ENOV)
NYSE · Healthcare
Enovis Corporation Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 2.25B | 2.11B | 1.71B | 1.56B | 1.43B | 1.12B | 3.33B | 2.19B | 1.94B | 3.19B | 3.43B | 4.62B | 4.21B | 3.91B | 693.4M | 542.0M | 525.0M |
| Gross Profit | 1.35B | 1.18B | 990.8M | 869.4M | 777.7M | 603.6M | 1.40B | 729.4M | 671.6M | 992.4M | 1.07B | 1.48B | 1.31B | 1.15B | 240.1M | 191.4M | 185.8M |
| Profitability | |||||||||||||||||
| Operating Income | -1.12B | -775.7M | -65.7M | -71.2M | -62.8M | -66.2M | 203.6M | 151.5M | 135.6M | 236.8M | 265.6M | 409.6M | 406.4M | 140.0M | 25.9M | 34.4M | 39.6M |
| EBITDA | 219.9M | 152.1M | 151.4M | 131.8M | 124.2M | 101.7M | 419.2M | 232.7M | 208.3M | 365.7M | 402.7M | 584.3M | 525.6M | 323.4M | 48.5M | 51.2M | — |
| Net Income | -1.18B | -825.5M | -33.3M | -13.3M | 71.7M | 42.6M | -527.6M | 140.2M | 151.1M | 128.1M | 167.7M | 392.1M | 178.6M | -64.4M | 4.6M | 16.2M | 23.8M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | $-20.75 | $-14.93 | $-0.61 | $-0.25 | $1.40 | $0.93 | $-3.89 | $1.16 | $1.22 | $1.04 | $1.34 | $3.02 | $1.54 | $-0.92 | $0.10 | $0.37 | — |
| Shares Outstanding (dil.) | 57M | 55M | 54M | 54M | 51M | 46M | 137M | 121M | 124M | 123M | 125M | 123M | 100M | 91M | 44M | 44M | — |
Enovis Corporation Income Statement — FAQ
Enovis Corporation (ENOV) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENOV's income statement history?
The chart and table above show Enovis Corporation's income statement by year and by quarter, including the growth rate.